These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 27967219

  • 1. A SURVEY OF CLINICAL PRACTICE PATTERNS IN MANAGEMENT OF GRAVES DISEASE IN THE MIDDLE EAST AND NORTH AFRICA.
    Beshyah SA, Khalil AB, Sherif IH, Benbarka MM, Raza SA, Hussein W, Alzahrani AS, Chadli A.
    Endocr Pract; 2017 Mar; 23(3):299-308. PubMed ID: 27967219
    [Abstract] [Full Text] [Related]

  • 2. A 2013 European survey of clinical practice patterns in the management of Graves' disease.
    Bartalena L, Burch HB, Burman KD, Kahaly GJ.
    Clin Endocrinol (Oxf); 2016 Jan; 84(1):115-20. PubMed ID: 25581877
    [Abstract] [Full Text] [Related]

  • 3. 2021 Asia-Pacific Graves' Disease Consortium Survey of Clinical Practice Patterns in the Management of Graves' Disease.
    Parameswaran R, de Jong MC, Kit JLW, Sek K, Nam TQ, Thang TV, Khue NT, Aye TT, Tun PM, Cole T, Miller JA, Villa M, Khiewvan B, Sirinvaravong S, Sin YL, Muhammad R, Jap TS, Agrawal A, Rajput R, Fernando R, Sumanatilleke M, Suastika K, Shong YK, Lang B, Bartalena L, Yang SP, Asian Graves Consortium Study.
    Endocrine; 2023 Jan; 79(1):135-142. PubMed ID: 36129592
    [Abstract] [Full Text] [Related]

  • 4. The management of Graves' disease in New Zealand 2014.
    Cox SC, Tamatea JA, Conaglen JV, Elston MS.
    N Z Med J; 2016 Jun 10; 129(1436):10-24. PubMed ID: 27355225
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Fluctuations in the titers of anti-thyroid hormone and anti-thyroglobulin antibodies in 4 cases of Graves' disease during long-term treatment period].
    Komaki T, Sakata S, Nakamura S, Matsuda M, Kojima N, Takuno H, Miura K.
    Nihon Naibunpi Gakkai Zasshi; 1989 Jul 20; 65(7):627-39. PubMed ID: 2583311
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study.
    Glinoer D, de Nayer P, Bex M, Belgian Collaborative Study Group on Graves' Disease.
    Eur J Endocrinol; 2001 May 20; 144(5):475-83. PubMed ID: 11331213
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A 2011 survey of clinical practice patterns in the management of Graves' disease.
    Burch HB, Burman KD, Cooper DS.
    J Clin Endocrinol Metab; 2012 Dec 20; 97(12):4549-58. PubMed ID: 23043191
    [Abstract] [Full Text] [Related]

  • 19. T4 but not T3 administration is associated with increased recurrence of Graves' disease after successful medical therapy.
    Mastorakos G, Doufas AG, Mantzos E, Mantzos J, Koutras DA.
    J Endocrinol Invest; 2003 Oct 20; 26(10):979-84. PubMed ID: 14759070
    [Abstract] [Full Text] [Related]

  • 20. Diagnosis and Management of Graves' Disease in Thailand: A Survey of Current Practice.
    Sriphrapradang C.
    J Thyroid Res; 2020 Oct 20; 2020():8175712. PubMed ID: 32454522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.